Protagonist Therapeutics (PTGX) Return on Invested Capital (2018 - 2025)
Historic Return on Invested Capital for Protagonist Therapeutics (PTGX) over the last 6 years, with Q3 2025 value amounting to 0.03%.
- Protagonist Therapeutics' Return on Invested Capital fell 2500.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of 0.49% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Protagonist Therapeutics' Return on Invested Capital is 0.03%, which was down 2500.0% from 0.03% recorded in Q2 2025.
- In the past 5 years, Protagonist Therapeutics' Return on Invested Capital ranged from a high of 0.41% in Q4 2024 and a low of 0.26% during Q1 2021
- In the last 3 years, Protagonist Therapeutics' Return on Invested Capital had a median value of 0.16% in 2024 and averaged 0.14%.
- Per our database at Business Quant, Protagonist Therapeutics' Return on Invested Capital surged by 7800bps in 2021 and then crashed by -2900bps in 2025.
- Quarter analysis of 3 years shows Protagonist Therapeutics' Return on Invested Capital stood at 0.26% in 2021, then soared by 259bps to 0.41% in 2024, then tumbled by -93bps to 0.03% in 2025.
- Its Return on Invested Capital was 0.03% in Q3 2025, compared to 0.03% in Q2 2025 and 0.04% in Q1 2025.